Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology Head, Neck, Orbit and Salivary Glands... 12

Size: px
Start display at page:

Download "Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12"

Transcription

1 Contents 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1 Complications 1 Fine Needle Aspiration Technique 1 Evaluation of FNAC Smear 4 Cell Morphology 4 Nucleus 4 Cytoplasm 6 Background Acellular Materials 7 Diagnostic Difficulties Head, Neck, Orbit and Salivary Glands Head and Neck 12 Non-neoplastic Lesions 12 Diagnostic Difficulties 13 Neoplastic Lesions 13 Paraganglioma 13 Nasopharyngeal Carcinoma 14 Ameloblastoma 15 Parathyroid Tumors 16 Meningioma 16 Salivary Gland 17 Clinical History 17 Aspirated Material 17 Normal Salivary Gland Cells 17 Lesions of the Salivary Gland 18 Sialadenosis 18 Cysts 19 Acute Sialadenitis 19 Chronic Sialadenitis 19 Autoimmune Sialadenitis and Benign Lymphoepithelial Lesions 19 Diagnostic Difficulties 19 Neoplasm 20 Benign 20 Warthin s Tumor 22 Basal Cell Adenoma (BCA) 23 Oncocytoma 23 Myoepithelial Tumors 24 Malignant Tumors 24 Adenoid Cystic Carcinoma (ACC) 24 Acinic Cell Carcinoma 26 Mucoepidermoid Carcinoma 27 Polymorphous Low Grade Adenocarcinoma (PLGA) 27 Other Tumors 28 Metastatic Malignancy 28 Approach to Salivary Gland Lesions 28 Orbital Lesions 29 Eyelid 29 Neoplasms 29 Retinoblastoma 29 Diagnostic Difficulty 30

2 Fine Needle Aspiration Cytology: Interpretation and Diagnostic Difficulties Malignant Melanoma 30 Lymphomas 30 Optic Glioma 30 Rhabdomyosarcoma 30 Metastatic Malignancy 30 Granulocytic Sarcoma Thyroid Approach to FNAC of the Thyroid 33 Clinical History and Physical Examination 33 Other Investigations 33 Techniques 33 Optimal Material 33 Normal Aspirated Material 33 Terminology 34 Lesions 34 Nodular Colloid Goiter 35 Diagnostic Difficulties 35 Adenomatoid Nodule/Hyperplastic Nodule 35 Diagnostic Difficulties 36 Diffuse Toxic Goiter 36 Thyroiditis 36 Acute Thyroiditis 36 Diagnostic Difficulties 36 Subacute Granulomatous Thyroiditis 36 Diagnostic Difficulties 37 Chronic Lymphocytic Thyroiditis 37 Diagnostic Difficulties 37 Follicular Neoplasm 37 Diagnostic Difficulties 39 Hurthle Cell Neoplasm 40 Diagnostic Difficulties 40 Papillary Carcinoma 40 Variants of Papillary Carcinoma of Thyroid 41 Diagnostic Difficulties of Usual PC 43 Variants of Papillary Carcinomas: Diagnostic Difficulties 43 Medullary Carcinoma (MC) 43 Immunocytochemistry 45 Diagnostic Difficulties 45 Anaplastic Carcinoma 45 Diagnostic Difficulties 46 Insular Carcinoma 46 Diagnostic Difficulties 46 Lymphomas 47 Diagnostic Difficulties 47 Metastatic Malignant Tumors 47 Diagnostic Difficulties 47 Ancillary Techniques 48 xiv 4. Breast Indications of FNAC of Breast 51 Diagnostic Accuracy 51 Overall Approach 51 Clinical History 51 Mammography 51 Triple Test 52

3 Contents Core Needle Biopsy Versus FNAC 52 Fine Needle Aspiration Techniques 52 Is this Sample Adequate? 52 Normal Breast FNAC 52 Approach to FNAC of Breast Lesions 52 Inflammatory Lesions 54 Acute Inflammation 54 Granulomatous Mastitis 54 Tuberculous Mastitis 54 Fat Necrosis 55 Benign Lesions 55 Fibroadenoma 55 Fibrocystic Disease 57 Diagnostic Difficulties 58 Galactocele 58 Lactating Adenoma 58 Diagnostic Difficulty 59 Proliferative Breast Disease with Atypia 59 Diagnostic Difficulties 59 Ductal Carcinoma In Situ 60 Diagnostic Difficulty 60 Phyllodes Tumor 60 Diagnostic Difficulties 61 Papillary Lesions of the Breast 62 Diagnostic Difficulties 62 Carcinoma 62 Diagnostic Difficulties 63 Other Types 63 Medullary Carcinoma 63 Diagnostic Difficulties 64 Mucinous Carcinoma (Colloid Carcinoma) 64 Diagnostic Difficulties 64 Apocrine Carcinoma 65 Diagnostic Difficulties 65 Tubular Carcinoma 65 Diagnostic Difficulties 66 Metaplastic Carcinoma 66 Lobular Carcinoma 66 Diagnostic Difficulties 67 Paget s Disease 67 Diagnostic Challenges 67 Other Uncommon Malignancies 67 Male Breast Lesions 68 Diagnostic Difficulties 68 Carcinoma in Male Breast 68 Ancillary Investigations on Breast Aspiration Material 68 Immunocytochemistry 68 Reporting of Breast FNAC 69 Cytological Grade 69 Diagnostic Pitfalls in Breast FNAC Lung Normal and Benign Cells 72 Inflammatory Lesions 73 Acute Inflammation 73 Diagnostic Difficulties 73 Specific Infections 73 xv

4 Fine Needle Aspiration Cytology: Interpretation and Diagnostic Difficulties Granulomatous Inflammation 74 Diagnostic Difficulties 74 Lung Carcinomas 75 Squamous Cell Carcinoma 75 Diagnostic Difficulties 76 Bronchogenic Adenocarcinoma 76 Diagnostic Difficulties 76 Bronchioloalveolar Carcinoma (BAC) 76 Diagnostic Difficulties 77 Small Cell Carcinoma 78 Immunocytochemistry 78 Diagnostic Difficulties 78 Undifferentiated Large Cell Carcinoma 79 Diagnostic Difficulties 79 Carcinoid 79 Diagnostic Difficulties 81 Pulmonary Blastoma 81 Diagnostic Difficulties 81 Metastatic Malignancies 82 Pleura 82 Mesothelioma 82 Immunocytochemistry 83 Diagnostic Difficulties 83 xvi 6. Mediastinum Clinical History 85 Radiological Localization 85 Techniques 85 Lesions 85 Thymoma 85 Malignant Thymoma 87 Diagnostic Difficulties 87 Thymic Carcinoid 87 Atypical Carcinoid 87 Diagnostic Difficulty 87 Germ Cell Tumors 87 Mature Cystic Teratoma 88 Diagnostic Difficulties 88 Immature Teratoma 88 Germinomas 88 Diagnostic Difficulty 88 Embryonal Carcinoma 89 Diagnostic Difficulty 89 Endodermal Sinus Tumor 89 Lymphomas 89 Non-Hodgkin s Lymphoma (NHL) 89 Large Cell NHL 89 Diagnostic Difficulty 89 Lymphoblastic Lymphoma 90 Diagnostic Difficulty 90 Hodgkin s Lymphoma 90 Diagnostic Difficulty 90 Neurogenic Tumor 90 Neuroblastoma 91 Diagnostic Difficulty 91 Ganglioneuroblastoma 91 Peripheral Nerve Sheath Tumor 91 Neurofibroma and Schwannoma 91

5 Contents Malignant Peripheral Nerve Sheath Tumors 91 Diagnostic Difficulties 92 Paraganglioma 92 Metastatic Carcinoma 92 Approach to the Diagnosis of Mediastinal Tumors Lymph Node Approach 96 Clinical History 96 Physical Findings 96 Aspiration 96 Normal Component of a Lymph Node 97 Follicular Center Cells 97 Reactive Lymphoid Hyperplasia 98 Diagnostic Difficulties 98 Acute Lymphadenitis 99 Cytology 99 Granulomatous Lymphadenitis 99 Diagnostic Difficulties 101 Rosai-Dorfman Disease 101 Diagnostic Difficulties 101 Kimura s Disease 102 Diagnostic Difficulties 102 Kikuchi s Disease 102 Diagnostic Difficulties 102 HIV Lymphadenopathy 102 Langerhans Cell Histiocytosis (LCH) 102 Diagnostic Difficulties 103 Dermatopathic Lymphadenitis 103 Diagnostic Difficulties 104 Metastatic Malignant Tumor 104 Diagnostic Difficulties 105 Lymphomas 105 Lymphoma Classification 105 B Cell Small Lymphocytic Lymphoma (SLL) 106 Mantle Cell Lymphoma (MCL) 107 Follicular Center Cell (FCC) Lymphoma 107 Marginal Zone Lymphoma 108 Diffuse Large B Cell Lymphoma 108 Centroblastic 109 Immunoblastic 109 T Cell/Histiocytes Rich 109 Anaplastic 109 B Lymphoblastic Lymphoma 110 Burkitt Lymphoma 111 T Cell Chronic Lymphocytic Lymphoma 111 T Lymphoblastic Lymphoma 112 Anaplastic Large Cell Lymphoma (ALCL) 112 Hodgkin s Lymphoma (HL) 112 Diagnostic Difficulties 114 Leukemic Infiltration 114 Diagnostic Difficulty Liver, Spleen, Pancreas and Gastrointestinal Tract Liver 118 Normal Cells 118 Liver Lesions 119 xvii

6 Fine Needle Aspiration Cytology: Interpretation and Diagnostic Difficulties Non-neoplastic Lesions 119 Cysts 119 Benign Neoplastic Lesion 119 Liver Cell Adenomas 119 Malignant Tumors 120 Hepatocellular Carcinoma (HCC) 120 Fibrolamellar Variant of HCC 122 Clear Cell Variant 122 Giant Cell Variant of HCC 122 Small Cell Variant 122 Spindle Cell Variant 122 Diagnostic Difficulties 122 Cholangiocarcinoma 122 Diagnostic Difficulties 123 Hepatoblastoma 123 Diagnostic Difficulties 123 Metastatic Malignancies 123 Diagnostic Difficulties 124 Spleen 124 Non-neoplastic Process 125 Granulomatous Infection 125 Storage Disorders 125 Neoplasm 125 Lymphoma 125 Pancreas 125 Normal Cells 125 Lesions 126 Cystic Lesions of Pancreas 126 Mucinous Neoplasia 126 Pancreatic Pseudocyst 126 Carcinoma 126 Ductal Adenocarcinoma 126 Other Types of Carcinoma 127 Pancreatic Acinar Carcinoma 127 Neuroendocrine Tumor 128 Islet Cell Tumor of Pancreas 128 Solid and Cystic Papillary Neoplasm (SCPN) of Pancreas 129 Diagnostic Difficulties 130 Gastrointestinal Tumors 130 Adenocarcinoma 130 Signet Ring Cell Adenocarcinoma 130 Carcinoid Tumors of the Small Intestine 131 Diagnostic Difficulties 131 Gastrointestinal Stromal Tumor (GIST) 132 Diagnostic Difficulties 132 Primary Small Intestinal Lymphomas 132 xviii 9. Kidney and Adrenal Normal Cells 134 Renal Lesions 134 Diagnostic Difficulty 135 Xanthogranulomatous Inflammation 135 Angiomyolipoma 135 Renal Cell Carcinoma (RCC) 136 The Other Variants of RCC 137 Oncocytoma 138 Transitional Cell Carcinoma (TCC) 139

7 Contents Pediatric Renal Tumors 139 Wilms Tumor 139 Mesoblastic Nephroma 140 Rhabdoid Tumor 140 Diagnostic Difficulty 141 Clear Cell Sarcoma 141 Lesions 141 Adrenocortical Carcinoma 141 Pheochromocytoma 141 Metastatic Tumors Gonads and Prostate Testis 145 Peritesticular Lesions 145 Hydrocele 145 Spermatocele 145 Inflammation 145 Spermatocytic Granuloma 145 Other Tumors 146 Neoplasms of Testis 146 Seminoma 146 Embryonal Carcinoma 147 Yolk Sac Tumor 147 Choriocarcinoma 148 Other Tumors of Testis 148 Evaluation of Male Infertility 148 Female Genital System 149 Ovarian Tumor 149 Serous and Mucinous Adenocarcinoma 149 Clear Cell Carcinoma 149 Diagnostic Difficulties 149 Germ Cell Tumor 150 Immature Teratoma 150 Granulosa Cell Tumor 150 Prostate 151 Benign Prostatic Hyperplasia 151 Carcinoma 152 Diagnostic Difficulties Soft Tissue Lesions and Skin Different Lesions 155 Lipoma and its Variants 155 Fibromatosis 156 Nodular Fasciitis 157 Benign Peripheral Nerve Sheath Tumor 157 Myositis Ossificans 157 Giant Cell Tumor of Tendon Sheath 158 Malignant Tumor 158 Liposarcomas 158 Well-differentiated Liposarcoma 158 Malignant Peripheral Nerve Sheath Tumor (MPNST) 160 Fibrosarcoma 160 Malignant Fibrous Histiocytoma 162 Synovial Sarcoma 163 Cytology 163 Rhabdomyosarcoma 164 Leiomyosarcomas 165 xix

8 Fine Needle Aspiration Cytology: Interpretation and Diagnostic Difficulties Clear Cell Sarcoma 165 Epithelioid Sarcomas 166 Alveolar Soft Part Sarcomas 166 Hemangiopericytoma 166 Skin 166 Inflammation 166 Pilomatrixoma 167 Basal Cell Carcinoma 167 Granular Cell Tumor 168 Meibomian Carcinoma 168 Malignant Melanoma 169 Malignant Sweat Gland Tumor 170 Markel Cell Tumor 170 Metastasis 170 Diagnostic Difficulties 170 Miscellaneous Bone Normal Cells 173 Osteosarcoma 173 Diagnostic Difficulties 174 Chondrosarcoma 175 Diagnostic Difficulty 176 Giant Cell Tumor of Bone (GCT) 176 Diagnostic Difficulty 176 Chondroblastoma 177 Diagnostic Difficulty 177 Chordoma 177 Diagnostic Difficulties 178 Ewing s Sarcoma 178 Diagnostic Difficulty 179 Non-Hodgkin s Lymphoma 179 Metastatic Carcinoma 179 Plasma Cell Neoplasm 179 Diagnostic Difficulty 180 Langerhans Cell Histiocytosis 180 Diagnostic Difficulty Round Cell Tumor Fine Needle Aspiration 182 Cytomorphology 182 Neuroblastoma 184 Ewing s Sarcoma (EWS) and Peripheral Neuroectodermal Tumor (PNET) 185 Wilms Tumor (WT) 185 Rhabdomyosarcoma (RMS) 185 Desmoplastic Small Round Cell Tumor (DSRCT) 185 Index xx

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,

More information

MODERN IMMUNOHISTOCHEMISTRY

MODERN IMMUNOHISTOCHEMISTRY MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,

More information

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Publishing Team Erik Tanck (production manager/designer) Joshua Weikersheimer (publisher) Copyright 2006 by the American Society

More information

Immunohistochemical differentiation of metastatic tumours

Immunohistochemical differentiation of metastatic tumours Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in

More information

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause. Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic

More information

Pediatric Oncology for Otolaryngologists

Pediatric Oncology for Otolaryngologists Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department

More information

Pathology of lung cancer

Pathology of lung cancer Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu

More information

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses Page 1 of 5 THE PATHOLOGY OF MEDIASTINAL MASSES Dr. S. Boag 549-6666 Ext. 4190, mailto:%20boag@cliff.path.queensu.ca 1. INTRODUCTION A wide range of process, neoplastic and non-neoplastic, can produce

More information

Update on Mesothelioma

Update on Mesothelioma November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical

More information

INDEX. Performance Improvement Program in Surgical Pathology SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS

INDEX. Performance Improvement Program in Surgical Pathology SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS INDEX SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS Performance Improvement Program in Surgical Pathology PIP CASE SUMMARY INDEX 1989-2012 Breast 89-17 Angiosarcoma 86% 89-37 Tubular adenoma 97%

More information

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Chapter Sixteen Oncology bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o Combining Forms Prefixes and Suffixes Carcinogenesis anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Causes of cancer

More information

Immunohistochemistry of soft tissue tumors

Immunohistochemistry of soft tissue tumors Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated

More information

New Hampshire Childhood Cancer

New Hampshire Childhood Cancer Introduction: New Hampshire Childhood Cancer New Hampshire, Childhood Cancer, January 2009 Issue Brief Cancer in children is relatively uncommon, impacting fewer than twenty two of every 100,000 children

More information

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,

More information

Diagnosis of Mesothelioma Pitfalls and Practical Information

Diagnosis of Mesothelioma Pitfalls and Practical Information Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied

More information

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

This module consists of four units which will provide the user a basic knowledge of cancer as a disease. Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define

More information

Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver

Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver Topic-Adenocarcinoma, Lung Figure 1. Pulmonary adenocarcinoma. Figure 2. Pulmonary bronchiolar carcinoma. Figure 3. Pulmonary fibrosarcoma. Topic-Adenocarcinoma, Skin (Sweat Gland, Sebaceous) Figure 1.

More information

INDEX. in this web service Cambridge University Press. References to Figures are in bold.

INDEX. in this web service Cambridge University Press. References to Figures are in bold. References to Figures are in bold. AAH (atypical adenomatous hyperplasia) 124 125 abscesses 33, 35 amebic 48 ACC (adenoid cystic carcinoma) 179, 179 180, 180, 181 acinar adenocarcinoma 126 127 moderately

More information

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:

More information

Frozen Section Diagnosis

Frozen Section Diagnosis Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The

More information

Lessons from a consultation practice

Lessons from a consultation practice Pitfalls in the Application of Immunohistochemistry in Diagnostic Pathology Lessons from a consultation practice Kevin O. Leslie, MD Professor and Consultant Mayo Clinic Arizona Scottsdale, Arizona Presenter

More information

BIOBANK LPCE-NICE CHEST

BIOBANK LPCE-NICE CHEST BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 LE / HU Unit atient : N LH13-3603 N LB 13-0691 ID : RO A onsent : YES Age : 54 Diagnosis and staging : chronic pleuresia 5x1000µL BIOBANK LE-NIE HEST

More information

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Lung Cancer Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Alexandria, Egypt July 1-1 3, 2008 OBJECTIVES Describe and

More information

FRCPath Part 2 Histopathology Short Cases, autumn 2014

FRCPath Part 2 Histopathology Short Cases, autumn 2014 FRCPath Part 2 Histopathology Short Cases, autumn 2014 Commentary Case 1 Female age 52: palpable lesion, left breast Breast, fat necrosis. Average: 2.6/5 This case was chosen as a good example of fat necrosis

More information

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used? Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or

More information

Something Old, Something New.

Something Old, Something New. Something Old, Something New. Michelle A. Fajardo, D.O. Loma Linda University Medical Center Clinical Presentation 6 year old boy, presented with hematuria Renal mass demonstrated by ultrasound & CT scan

More information

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Disclosures Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! No Relevant Financial Relationships with Commercial Interests Syed Z. Ali, M.D. Syed Z. Ali, M.D. Associate Professor of

More information

PROTOCOL OF THE RITA DATA QUALITY STUDY

PROTOCOL OF THE RITA DATA QUALITY STUDY PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of

More information

Leukemias and Lymphomas: A primer

Leukemias and Lymphomas: A primer Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes

More information

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS The evolving pathology of solitary fibrous tumours Luciane Dreher Irion MREH / CMFT / NSOPS Historical review Haemangiopericytoma (HPC) first described primarily as a soft tissue vascular tumour of pericytic

More information

NEOPLASMS C00 D49. Presented by Jan Halloran CCS

NEOPLASMS C00 D49. Presented by Jan Halloran CCS NEOPLASMS C00 D49 Presented by Jan Halloran CCS 1 INTRODUCTION A neoplasm is a new or abnormal growth. In the ICD-10-CM classification system, neoplastic disease is classified in categories C00 through

More information

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma

More information

Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin

Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin Rodney T. Miller, M.D. Director of Immunohistochemistry ProPath Laboratory 1355 River Bend Drive Dallas, TX 75247-4915

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

The Diagnosis of Cancer in the Pathology Laboratory

The Diagnosis of Cancer in the Pathology Laboratory The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens

More information

History. Female age 64. Tumour right kidney on scan. Partial nephrectomy. Tumour 18mm diameter.

History. Female age 64. Tumour right kidney on scan. Partial nephrectomy. Tumour 18mm diameter. FRCPath Part 2 Histopathology Examination Histology short cases Commentary. Case 1. History. Female age 64. Tumour right kidney on scan. Partial nephrectomy. Tumour 18mm diameter. Diagnosis: Angiomyolipoma

More information

YOUR LUNG CANCER PATHOLOGY REPORT

YOUR LUNG CANCER PATHOLOGY REPORT UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7

More information

How To Test For Cancer

How To Test For Cancer Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Effusion = Confusion Syed Z. Ali, M.D. Professor of Pathology and Radiology The Johns Hopkins Hospital Baltimore, Maryland Diagnostic

More information

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc. Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Cytology of Lymph Nodes

Cytology of Lymph Nodes Indications Cytology of Lymph Nodes Lymph node enlargement That was easy Mary Anna Thrall Don Meuten Indications Lymph node enlargement Suspect metastasis Normal sized lymph nodes are Normal Do NOT aspirate

More information

A guide to cancer types and chemotherapy medications

A guide to cancer types and chemotherapy medications A guide to cancer types and chemotherapy medications This guides lists words that mean cancer, cancer types and intravenous chemotherapy medications. If you have any questions, see page 10 for details

More information

ADOPTED REGULATION OF THE STATE BOARD OF HEALTH. LCB File No. R075-98. Effective November 18, 1998

ADOPTED REGULATION OF THE STATE BOARD OF HEALTH. LCB File No. R075-98. Effective November 18, 1998 ADOPTED REGULATION OF THE STATE BOARD OF HEALTH LCB File No. R075-98 Effective November 18, 1998 EXPLANATION Matter in italics is new; matter in brackets [ ] is material to be omitted. AUTHORITY: 2-13,

More information

FNA Cytology of Mediastinal Lesions. Presenters: Xiaoqi Lin, M.D., Ph.D. Ritu Nayar, M.D.

FNA Cytology of Mediastinal Lesions. Presenters: Xiaoqi Lin, M.D., Ph.D. Ritu Nayar, M.D. Disclosure information The speakers have no relationship that represents a possible conflict of interest with respect to the content of this presentation. FNA Cytology of Mediastinal Lesions Presenters:

More information

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D. Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are

More information

Practical Effusion Cytology

Practical Effusion Cytology Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.

More information

Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control

Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control Oncology Objectives Describe the etiology and pathophysiological mechanisms of cancer Discuss medical and family history findings relevant to cancer Identify general signs and symptoms associated with

More information

Malignant Lymphomas and Plasma Cell Myeloma

Malignant Lymphomas and Plasma Cell Myeloma Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations

More information

BERGEN COMMUNITY COLLEGE DIAGNOSTIC MEDICAL SONOGRAPHY PROGRAM Division of Health Professions DMS 213 SYLLABUS

BERGEN COMMUNITY COLLEGE DIAGNOSTIC MEDICAL SONOGRAPHY PROGRAM Division of Health Professions DMS 213 SYLLABUS BERGEN COMMUNITY COLLEGE DIAGNOSTIC MEDICAL SONOGRAPHY PROGRAM Division of Health Professions DMS 213 SYLLABUS Course Title: DMS 213 - Abdominal Sonography 2 2 lec. 3 lab. 3 credits (5 hours) Required

More information

Nuno Morais 1 José António Moreira da Costa 2

Nuno Morais 1 José António Moreira da Costa 2 Nuno Morais 1 José António Moreira da Costa 2 1 Neurosurgery Department, Hospital de Braga, Braga, Portugal 2 Private Practice, Clínica Neurológica e da Coluna Vertebral, Braga, Portugal Disclosure Funding

More information

Effusions: Mesothelioma and Metastatic Cancers

Effusions: Mesothelioma and Metastatic Cancers Effusions: Mesothelioma and Metastatic Cancers Malignant Mesothelioma Incidence: 2,500 cases/year ~60-80% pts with pleural MM relationship with asbestos exposure Other risk factors: radiation, other carcinogens,

More information

LCD for Erythrocyte Sedimentation Rate (ESR)

LCD for Erythrocyte Sedimentation Rate (ESR) LCD for Erythrocyte Sedimentation Rate (ESR) Applicable CPT Code(s): 85651 Sedimentation Rate, Erythrocyte; Non-Automated 85652 Sedimentation Rate, Erythrocyte; Automated ICD-9 Codes that Support Medical

More information

Oncology Best Practice Documentation

Oncology Best Practice Documentation Oncology Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Solid Tumors Lymphomas Leukemias Myelodysplastic Syndrome Pathology Findings

More information

Cancer and how your policy works. General & Medical

Cancer and how your policy works. General & Medical Cancer and how your policy works General & Medical This booklet, like others in our information book series are designed to help you understand the various aspects of General & Medical private healthcare

More information

How To Test For Cancer With A Blood Test

How To Test For Cancer With A Blood Test Histolab Products AB Eva Alströmer Jonas Falgén Helsingborg 7-8/10 2010 Table 1 Formalin Fixation Times and Estrogen Receptor Staining With 25 Minutes Antigen Retrieval Pretreatment Formalin Q-Score Difference

More information

Chapter I Overview Chapter Contents

Chapter I Overview Chapter Contents Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality

More information

Histopathology of Major Salivary Gland Neoplasms

Histopathology of Major Salivary Gland Neoplasms Histopathology of Major Salivary Gland Neoplasms Sam J. Cunningham, MD, PhD Faculty Advisor: Shawn D. Newlands, MD, PhD Faculty Advisor: David C. Teller, MD The University of Texas Medical Branch, Department

More information

Pleural and Chest Wall Tumors

Pleural and Chest Wall Tumors Pleural and Chest Wall Tumors Ritu Gill, MD, MPH Dr. Ritu R. Gill Department t of Radiology Brigham and Women s Hospital Harvard Medical School CLASSIFICATION OF CHEST WALL TUMORS Primary neoplasm of chest

More information

Tumor Patterns. Common Morphologic Patterns in Soft Tissue Tumors. Update on Lipomatous Tumors. MFH-like. Highly cellular spindle cell pattern

Tumor Patterns. Common Morphologic Patterns in Soft Tissue Tumors. Update on Lipomatous Tumors. MFH-like. Highly cellular spindle cell pattern Common Morphologic Patterns in Soft Tissue Tumors John R. Goldblum, M.D. Chairman, Department of Anatomic Pathology The Cleveland Clinic Professor of Pathology Cleveland Clinic Lerner College of Medicine

More information

NLSY79 ATTACHMENT 8: HEALTH CODES

NLSY79 ATTACHMENT 8: HEALTH CODES NLSY79 ATTACHMENT 8: HEALTH CODES 1 GENERAL INFORMATION ON HEALTH CODES The health section of the NLS survey elicits health problems that limit the amount or kind of work the respondent can do. Those health

More information

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE HISTORY 52Y MALE RIGHT RADICAL NEPHERECTOMY Case of right renal mass with IVC thrombus. History of surgery and RT for right occipital

More information

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there Friend for Life Cancer Support Network Annual Report 2010 Facing cancer, with someone who s been there This is wonderful support for those of us who are newly diagnosed with cancer. Our Mission To help

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

Grossing & Intraoperative Evaluation Boot Camp

Grossing & Intraoperative Evaluation Boot Camp AP RTC July 2011 Moffitt: HSW- 532 Zion: B2 Conf. Room MON TUES WED THURS FRI Grossing & Intraoperative Evaluation Boot Camp 4 5 6 Lymph node & general principles in gross pathology - Grossing principles

More information

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE Ryan Granger University of Rhode Island Cytotechnology program May 2, 2015 ASCT Annual Meeting Nashville, Tennessee DESMOPLASTIC SMALL ROUND

More information

日 本 病 理 学 会 中 国 四 国 支 部 学 術 集 会 ( 第 114 回 スライドカンファレンス) 診 断 投 票 結 果

日 本 病 理 学 会 中 国 四 国 支 部 学 術 集 会 ( 第 114 回 スライドカンファレンス) 診 断 投 票 結 果 日 本 病 理 学 会 中 国 四 国 支 部 学 術 集 会 ( 第 114 回 スライドカンファレンス) 診 断 投 票 結 果 平 成 26 年 6 月 14 日 高 知 大 学 医 学 部 臨 床 講 義 棟 第 3 講 義 室 S2509 頬 粘 膜 腫 瘍 *Speaker's diagnosis Solitary fibrous tumor 12 Solitary fibrous tumor

More information

Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls

Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls Aus dem Institut für Pathologie der Medizinischen Fakultät Charité Universitätsmedizin Berlin DISSERTATION Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls

More information

BIOBANK LPCE-NICE CHEST

BIOBANK LPCE-NICE CHEST BIOBANK LE-NIE HEST athologist : S. LASSALLE 01/03/2011 Time for frozen procedure : 10 mn LE / HU Unit atient : N LH 11-0004 N LB 11-0002 onsent : YES Age : 37 ID : TH ER Diagnosis and staging : Hodgkin

More information

Cardiac Masses and Tumors

Cardiac Masses and Tumors Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:

More information

190.25 - Alpha-fetoprotein

190.25 - Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

The WHO Classification of Renal Tumors and Common Issues in TNM Staging for Renal Cell Carcinoma

The WHO Classification of Renal Tumors and Common Issues in TNM Staging for Renal Cell Carcinoma The WHO Classification of Renal Tumors and Common Issues in TNM Staging for Renal Cell Carcinoma Steven Shen, M.D.,Ph.D. Staff Pathologist and Assistant Member The Methodsit Hospital and Research Institute

More information

VM104 TUMORS OF THE PLEURA AND MEDIASTINUM

VM104 TUMORS OF THE PLEURA AND MEDIASTINUM VM104 TUMORS OF THE PLEURA AND MEDIASTINUM Saul Suster, MD Ohio State University Hospital Columbus, OH University of Texas MD Anderson Cancer Center Houston, Texas September 19, 2004 Page 2 of 26 THYMOMAS

More information

Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification. Jesse K. McKenney, MD Associate Head, Surgical Pathology

Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification. Jesse K. McKenney, MD Associate Head, Surgical Pathology Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification Jesse K. McKenney, MD Associate Head, Surgical Pathology Renal Epithelial Neoplasia History 1981: WHO Classification of Renal Neoplasms 1.

More information

Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu

Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu Table of Contents Page Undifferentiated panel 1 CK7/20 table 2 Breast carcinoma

More information

Diagnostic Challenge. Department of Pathology,

Diagnostic Challenge. Department of Pathology, Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital

More information

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Department of Pathology University of Szeged, Hungary ISUP Vancouver Classification of Renal Neoplasia Am J Surg Pathol 37:14691489, 2013 13 histologic

More information

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion. Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case

More information

Cytopathology Case Presentation #8

Cytopathology Case Presentation #8 Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents

More information

How CanCer becomes critical in the claims

How CanCer becomes critical in the claims How CanCer becomes critical in the claims arena Cancer is a disease in which cells in your body grow in an uncontrolled way and form a lump called a tumour. In a healthy individual cells grow and reproduce

More information

The develpemental origin of mesothelium

The develpemental origin of mesothelium Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal

More information

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014 ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the

More information

Immunohistochemistry of clear cell tumours. What are clear cell tumours? Jan Klos 1

Immunohistochemistry of clear cell tumours. What are clear cell tumours? Jan Klos 1 Immunohistochemistry of clear cell tumours J. Klos MD Department of Pathology Stavanger University Hospital Norway What are clear cell tumours? Multiple factors in etiology of clear cell changes: - technical

More information

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd. Emerging Subtypes in Renal Cancer Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.edu Some General Comments Fuhrman nuclear grading clear cell

More information

Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT

Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT NCCN guidelines were reviewed on 3/25/2013 for utilization of 18 F-fluorodeoxyglucose (FDG) PET and PET/CT (available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp).

More information

PathMD: Board Review Letter TM

PathMD: Board Review Letter TM Questions 1. Mantle Cell Lymphoma is associated with which of the following: A. t(11;14) B. t(8;14) C. t(2;5) D. t(11;18) E. t(14;18) 2. A case of anaplastic large cell lymphoma (ALCL) with t(1;2) is stained

More information

Bone Marrow Evaluation for Lymphoma. Faizi Ali, MD Hematopathology Fellow William Beaumont Hospital

Bone Marrow Evaluation for Lymphoma. Faizi Ali, MD Hematopathology Fellow William Beaumont Hospital Bone Marrow Evaluation for Lymphoma Faizi Ali, MD Hematopathology Fellow William Beaumont Hospital Indications One of the most common indications for a bone marrow biopsy is to evaluate for malignant lymphoma.

More information

R-16: Chronic nonspecific cervisit

R-16: Chronic nonspecific cervisit R-16: Chronic nonspecific cervisit Ectoservikal squamous epithelium Endoservical columnar epithelium Dilated cystic endoservical glands lymphoplasmocytes R18:Squamous cell carcinoma insitu Neoplastic epithelium

More information

Histologic Subtypes of Renal Cell Carcinoma

Histologic Subtypes of Renal Cell Carcinoma Histologic Subtypes of Renal Cell Carcinoma M. Scott Lucia, MD Associate Professor Chief of Genitourinary and Renal Pathology Director, Prostate Diagnostic Laboratory Dept. of Pathology University of Colorado

More information

How To Diagnose And Treat A Tumour In An Effusion

How To Diagnose And Treat A Tumour In An Effusion Effusions of the Serous Cavities Annika Dejmek Professor/Consultant in Cytopathology Clinical Pathology; Department of Laboratory Medicine, Malmö, Lund University 5th EFCS Tutorial Trondheim 2012 Pleura

More information

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information.

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information. 5. PERICARDIUM Heart is encased by the pericardium which has a visceral layer (a) covering the heart and the parietal layer (b). In normal states it is thin, transparent and the myocardium can be seen

More information

CHAPTER 4 Specific tumor sites (part 1)

CHAPTER 4 Specific tumor sites (part 1) CANCER REGISTRATION HANDBOOK CHAPTER 4 Specific tumor sites (part 1) Contents IV(1)-2 IV(1)-2 IV(1)-3 IV(1)-3 IV(1)-3 IV(1)-3 IV(1)-4 IV(1)-4 IV(1)-7 IV(1)-7 IV(1)-7 IV(1)-8 IV(1)-8 IV(1)-8 IV(1)-9 IV(1)-9

More information

INFLAMMATORY PLEURAL EFFUSION

INFLAMMATORY PLEURAL EFFUSION PLEURA- LESIONS LESIONS OF PLEURA Primary Intra pleural bacterial infections Neoplasm (mesothelioma) Secondary A complication of some underlying disease PLEURAL EFFUSION Common manifestation of both primary

More information

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Renal tumours WHO 4 MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Molecular differential pathology of renal cell tumours G. KOVACS A CLASSIFICATION BASED ON UNDERSTANDING THE GENETIC

More information

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15 MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,

More information

NATIONAL INSTITUTES OF HEALTH National Cancer Institute. Neoplasms

NATIONAL INSTITUTES OF HEALTH National Cancer Institute. Neoplasms NATIONAL INSTITUTES OF HEALTH National Cancer Institute to Neoplasms CONVERSION of NEOPLASMS BY TOPOGRAPHY AND MORPHOLOGY from the INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY, SECOND EDITION

More information

page antibody Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9)

page antibody Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9) New IHC Antibodies 2 Table of Contents page antibody 1 2 3 4 5 6 7 8 Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9) Caveolin-1 (2297) CD13 (SP187) CD16 (SP175)

More information

Cervical lymphadenopathy

Cervical lymphadenopathy Cervical lymphadenopathy Introduction There are various classifications of lymphadenopathy, but a simple and clinically useful system is to classify lymphadenopathy as "generalized" if lymph nodes are

More information